Bendamustine hydrochloride injection

DRUG3 trials

Sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd., Shandong Lanjin Pharmaceuticals Co.,Ltd, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Lymphocytic LeukemiaIndolent B-Cell Non-Hodgkin's LymphomasLeukemiaNeoplasms

Phase 2

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

CompletedNCT01109264

Jiangsu Simcere Pharmaceutical Co., Ltd.Chronic Lymphocytic Leukemia

Start: 2010-03-31End: 2013-08-31Updated: 2013-08-23

A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

CompletedNCT04569838

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Indolent B-Cell Non-Hodgkin's Lymphomas

Start: 2012-05-31End: 2016-08-31Updated: 2020-09-30

Phase 3

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Shandong Lanjin Pharmaceuticals Co.,LtdChronic Lymphocytic Leukemia, Leukemia, Neoplasms

Start: 2011-01-31End: 2013-12-31Target: 96Updated: 2012-08-06